Consumer & Specialties sales were $278 million, up 4% sequentially; Household & Personal Care sales were $127 million, up 3% sequentially.
Engineered Solutions sales were $251 million, up 12% sequentially; High-Temperature Technologies sales were $178 million, 3% below prior year but up 5% sequentially.
Free cash flow was $34 million in Q2; CapEx was $29 million with full-year projection of approximately $100 million.
Liquidity stood at nearly $700 million with net leverage ratio at 1.7x EBITDA, below the 2x target.
Operating income for Consumer & Specialties was $37 million, up 24% sequentially with margin at 13.4%.
Operating income for Engineered Solutions was $44 million, with margin improving 200 basis points sequentially to 17.4%, matching last year's record.
Operating income was $79 million, up 25% sequentially, with operating margin at 14.9%, up 200 basis points from Q1.
Sales reached $529 million, an 8% sequential increase driven by higher volumes and favorable pricing.
Second quarter EPS was $1.55, up 36% sequentially and second only to last year's stronger Q2.
Strong cash conversion maintained at around 7% of sales, consistent with historical averages.
Adjusted Q2 operating profit was $5 million, significantly down from prior year, excluding $15 million in severance and asset impairment costs.
Bolzoni revenues declined year-over-year due to phasing out lower-margin legacy products, but showed sequential revenue growth.
Lift Truck segment margins were negatively impacted by $10 million in tariff-driven material and freight cost increases.
Net debt improved year-over-year due to excess cash generation and debt reduction; liquidity remains strong with nearly $260 million unused borrowing capacity.
Operating cash flow improved to approximately $30 million in Q2, driven by working capital management and inventory reductions.
Q2 2025 revenues declined 19% year-over-year due to lower volumes and tariff-related economic uncertainty.
Tax expense was $200,000 in Q2 compared to $26 million prior year, influenced by lower pretax earnings and capitalization of R&D costs.
Dafinchi